TABLE 2

Plasma Input Kinetic Data Using Time–Activity Curve Analysis

Pharmacokinetic parameterHRRT reconstruction methodUnfixed interceptFixed intercept to origin
SlopeInterceptrSloper
Logan VT3D-FBP1.15 ± 0.050.19 ± 0.430.97 ± 0.011.19 ± 0.100.97 ± 0.01
3D-FBP G61.03 ± 0.070.20 ± 0.340.98 ± 0.001.07 ± 0.110.98 ± 0.01
3D-OSWLS1.15 ± 0.05−0.03 ± 0.320.98 ± 0.001.14 ± 0.100.98 ± 0.00
3D-OSWLS G61.02 ± 0.070.09 ± 0.270.98 ± 0.001.04 ± 0.110.98 ± 0.00
BFM VT3D-FBP0.99 ± 0.211.21 ± 0.350.93 ± 0.031.29 ± 0.230.88 ± 0.05
3D-FBP G61.08 ± 0.17−0.16 ± 0.320.98 ± 0.011.04 ± 0.220.98 ± 0.01
3D-OSWLS1.14 ± 0.17−0.13 ± 0.450.98 ± 0.011.11 ± 0.220.97 ± 0.00
3D-OSWLS G61.08 ± 0.18−0.28 ± 0.280.98 ± 0.001.00 ± 0.210.98 ± 0.00
  • G6 = 6-mm FWHM gaussian kernel.

  • Slope, intercept, and r (all data are mean ± SD) of plasma input kinetic data using HRRT- vs. HR+-reconstructed scans of 5 subjects, over various ROIs.